DaVita Inc. (0I7E)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 181.27 |
|---|---|
| 52-week range | 101.01 – 250.00 |
| Return, 1 month / 3 months | +1.9% / −23.4% |
| Return, 1 year / 3 years | +40.0% / +136.0% |
| Trend | Uptrend |
| RSI (14) | 49 |
| Volatility (1 year) | 45.8% |
| Worst drawdown (1 year) | -28.8% |
| Average daily value traded | 0.09M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers, mainly in the United States, and also offers related laboratory and pharmacy services. Its patients are people with chronic kidney failure who need regular dialysis treatment, and the company works alongside physicians and hospitals in caring for them. DaVita is based in the United States and also runs dialysis operations in several other countries.
On this site DaVita Inc. appears as a stock on the London Stock Exchange (UK), code 0I7E, with prices in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
DaVita Inc. (0I7E) trades on the London Stock Exchange in UK. It last closed at USD 181.27 on 27 October 2026.
Its price-based Market X-Ray is 46 out of 100 (a weak price profile), ranking 2,287 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 40.0% and over the last three months it fell 23.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 50 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.4% | ||
| From 52-week high | -24.9% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -23.4% | ||
| 6-month return | 19.8% | ||
| 12-month return, skipping the last month | 37.3% | ||
| Stability (higher is calmer) | 41 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 45.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.8% | ||
| Liquidity | 29 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.09M USD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +3.6% |
|---|---|
| 1 month | +1.9% |
| 3 months | −23.4% |
| 6 months | +19.8% |
| 1 year | +40.0% |
| 3 years | +136.0% |
| 5 years | +62.9% |
Signals
| 50-day / 200-day average | 181.13 / 177.01 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.00 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.